The European and Developing Countries Clinical Trials Partnership has received the green light for its 2017 work plan. This unlocks clinical trials funding worth €156.5 million (US$178.8m), much of which will target Africa.
The European Commission approved EDCTP’s plan on 3 July. Five calls for proposals were issued on the same day: €30m for innovations for poverty-related diseases, €34m for large-scale clinical trials, €38m for clinical trials which target pregnant women and children, €19m for neglected infectious diseases clinical trials, and €11m for neglected infectious disease product research.
An €800,000 fellowship scheme opens for applications on 14 July in partnership with the Africa Research Excellence Fund. This programme will allow postdoctoral researchers from Africa to be hosted by a university in an EU partner country.
Two calls will open in August: €2.5m for building ethics and regulatory capacity in sub-Saharan Africa, and €2.5m for career-development fellowships for junior and mid-career clinical researchers.
Three final calls will be issued in October and November: a €3m fellowship programme placing developing country researchers in European pharmaceutical companies for training, a €3m partnership with drug company GlaxoSmithKline in comorbidities between poverty-related diseases and noncommunicable diseases, and the EDCTP senior fellowships, worth up to €500,000 each.
For more details on the calls follow the links to the right of this article.